Literature DB >> 33807786

Integrin αvβ3 Engagement Regulates Glucose Metabolism and Migration through Focal Adhesion Kinase (FAK) and Protein Arginine Methyltransferase 5 (PRMT5) in Glioblastoma Cells.

Pulin Che1, Lei Yu2, Gregory K Friedman3, Meimei Wang1, Xiaoxue Ke4, Huafeng Wang5,6, Wenbin Zhang5, Burt Nabors5, Qiang Ding1, Xiaosi Han5.   

Abstract

Metabolic reprogramming promotes glioblastoma cell migration and invasion. Integrin αvβ3 is one of the major integrin family members in glioblastoma multiforme cell surface mediating interactions with extracellular matrix proteins that are important for glioblastoma progression. The role of αvβ3 integrin in regulating metabolic reprogramming and its mechanism of action have not been determined in glioblastoma cells. Integrin αvβ3 engagement with osteopontin promotes glucose uptake and aerobic glycolysis, while inhibiting mitochondrial oxidative phosphorylation. Blocking or downregulation of integrin αvβ3 inhibits glucose uptake and aerobic glycolysis and promotes mitochondrial oxidative phosphorylation, resulting in decreased migration and growth in glioblastoma cells. Pharmacological inhibition of focal adhesion kinase (FAK) or downregulation of protein arginine methyltransferase 5 (PRMT5) blocks metabolic shift toward glycolysis and inhibits glioblastoma cell migration and invasion. These results support that integrin αvβ3 and osteopontin engagement plays an important role in promoting the metabolic shift toward glycolysis and inhibiting mitochondria oxidative phosphorylation in glioblastoma cells. The metabolic shift in cell energy metabolism is coupled to changes in migration, invasion, and growth, which are mediated by downstream FAK and PRMT5 in glioblastoma cells.

Entities:  

Keywords:  cancer; focal adhesion kinase; glioblastoma; integrin; invasion; metabolism; migration; proliferation; protein arginine methyltransferase 5

Year:  2021        PMID: 33807786      PMCID: PMC7961489          DOI: 10.3390/cancers13051111

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  54 in total

Review 1.  Anticancer agents that counteract tumor glycolysis.

Authors:  Carlotta Granchi; Filippo Minutolo
Journal:  ChemMedChem       Date:  2012-06-08       Impact factor: 3.466

2.  Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis.

Authors:  Yunfei Zhou; Yan Zhou; Takashi Shingu; Li Feng; Zhao Chen; Marcia Ogasawara; Michael J Keating; Seiji Kondo; Peng Huang
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

3.  p27Kip1 and cyclin D1 are necessary for focal adhesion kinase regulation of cell cycle progression in glioblastoma cells propagated in vitro and in vivo in the scid mouse brain.

Authors:  Qiang Ding; J Robert Grammer; Mark A Nelson; Jun-Lin Guan; Jerry E Stewart; Candece L Gladson
Journal:  J Biol Chem       Date:  2004-11-19       Impact factor: 5.157

4.  Small integrin binding ligand N-linked glycoprotein gene family expression in different cancers.

Authors:  Larry W Fisher; Alka Jain; Matt Tayback; Neal S Fedarko
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

5.  Detection of Mitochondrial Mass, Damage, and Reactive Oxygen Species by Flow Cytometry.

Authors:  Daniel Puleston
Journal:  Cold Spring Harb Protoc       Date:  2015-09-01

6.  Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma.

Authors:  Sharmistha Pal; Robert A Baiocchi; John C Byrd; Michael R Grever; Samson T Jacob; Saïd Sif
Journal:  EMBO J       Date:  2007-07-12       Impact factor: 11.598

Review 7.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

8.  Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis.

Authors:  J Zhang; Q Gao; Y Zhou; U Dier; N Hempel; S N Hochwald
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

9.  PRMT5 promotes cancer cell migration and invasion through the E2F pathway.

Authors:  Wojciech Barczak; Li Jin; Simon Mark Carr; Shonagh Munro; Samuel Ward; Alexander Kanapin; Anastasia Samsonova; Nicholas B La Thangue
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

10.  Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature.

Authors:  Oliver Schnell; Bjarne Krebs; Erika Wagner; Alexander Romagna; Ambros J Beer; Stefan J Grau; Niklas Thon; Claudia Goetz; Hans A Kretzschmar; Jörg-Christian Tonn; Roland H Goldbrunner
Journal:  Brain Pathol       Date:  2008-04-02       Impact factor: 6.508

View more
  3 in total

Review 1.  The complex relationship between integrins and oncolytic herpes Simplex Virus 1 in high-grade glioma therapeutics.

Authors:  Kimberly Ann Rivera-Caraballo; Mitra Nair; Tae Jin Lee; Balveen Kaur; Ji Young Yoo
Journal:  Mol Ther Oncolytics       Date:  2022-06-06       Impact factor: 6.311

2.  Integrin β3-PKM2 pathway-mediated aerobic glycolysis contributes to mechanical ventilation-induced pulmonary fibrosis.

Authors:  Shuya Mei; Qiaoyi Xu; Yue Hu; Ri Tang; Jinhua Feng; Yang Zhou; Shunpeng Xing; Yuan Gao; Zhengyu He
Journal:  Theranostics       Date:  2022-08-15       Impact factor: 11.600

3.  Generation of chromosome 1p/19q co-deletion by CRISPR/Cas9-guided genomic editing.

Authors:  Chao Li; Zhong Liu; Xiaoxia Zhang; Huafeng Wang; Gregory K Friedman; Qiang Ding; Xinyang Zhao; Hu Li; Kitai Kim; Xi Yu; L Burt Nabors; Xiaosi Han; Rui Zhao
Journal:  Neurooncol Adv       Date:  2022-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.